GRPR versus PSMA: expression profiles during prostate cancer progression demonstrate the added value of GRPR-targeting theranostic approaches

INTRODUCTION: Central to targeted radionuclide imaging and therapy of prostate cancer (PCa) are prostate-specific membrane antigen (PSMA)-targeting radiopharmaceuticals. Gastrin-releasing peptide receptor (GRPR) targeting has been proposed as a potential additional approach for PCa theranostics. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Verhoeven, Marjolein, Ruigrok, Eline A. M., van Leenders, Geert J. L. H., van den Brink, Lilian, Balcioglu, Hayri E., van Weerden, Wytske M., Dalm, Simone U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502172/
https://www.ncbi.nlm.nih.gov/pubmed/37719014
http://dx.doi.org/10.3389/fonc.2023.1199432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502172/
https://www.ncbi.nlm.nih.gov/pubmed/37719014
http://dx.doi.org/10.3389/fonc.2023.1199432

Ejemplares similares